Evidence map›Paper›PMID 32004476›Full record

ArticleCell metabolism2020

Macrophage Metabolism of Apoptotic Cell-Derived Arginine Promotes Continual Efferocytosis and Resolution of Injury.

Arif Yurdagul, Manikandan Subramanian, Xiaobo Wang, Scott B Crown, Olga R Ilkayeva, Lancia Darville, Gopi K Kolluru, Christina C Rymond, Brennan D Gerlach, Ze Zheng and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 326 papers.

0numbers the graph read from it
0cells of the map it votes in
326citing papers in PubMed
18.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

326 citing papers in PubMed, 475 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Compartmental pH regulation in cancer and antitumor immunity: therapeutic opportunities and challenges.Apoptosis : an international journal on programmed cell death · 2026
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

266 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Arif YurdagulDepartment of Medicine, Columbia University, New York, NY 10032, USA. Electronic address: ay2377@columbia.edu.
Manikandan SubramanianDepartment of Medicine, Columbia University, New York, NY 10032, USA; CSIR-Institute of Genomics and Integrative Biology, New Delhi 110025, India.
Xiaobo WangDepartment of Medicine, Columbia University, New York, NY 10032, USA.
Scott B CrownDepartments of Medicine and Pharmacology and Cancer Biology, Sarah W. Stedman Nutrition and Metabolism Center and Duke Molecular Physiology Institute, Duke University, Durham, NC 27701, USA.
Olga R IlkayevaDepartments of Medicine and Pharmacology and Cancer Biology, Sarah W. Stedman Nutrition and Metabolism Center and Duke Molecular Physiology Institute, Duke University, Durham, NC 27701, USA.
Lancia DarvilleProteomics and Metabolomics Core, Department of Molecular Oncology, and Department of Tumor Biology, Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
Gopi K KolluruDepartment of Pathology, Louisiana State University Health Sciences Center, Shreveport, Shreveport, LA 71103, USA.
Christina C RymondDepartment of Medicine, Columbia University, New York, NY 10032, USA.
Brennan D GerlachDepartment of Medicine, Columbia University, New York, NY 10032, USA.
Ze ZhengDepartment of Medicine, Columbia University, New York, NY 10032, USA.
George KuriakoseDepartment of Medicine, Columbia University, New York, NY 10032, USA.
Christopher G KevilDepartment of Pathology, Louisiana State University Health Sciences Center, Shreveport, Shreveport, LA 71103, USA.
John M KoomenProteomics and Metabolomics Core, Department of Molecular Oncology, and Department of Tumor Biology, Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
John L ClevelandProteomics and Metabolomics Core, Department of Molecular Oncology, and Department of Tumor Biology, Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
Deborah M MuoioDepartments of Medicine and Pharmacology and Cancer Biology, Sarah W. Stedman Nutrition and Metabolism Center and Duke Molecular Physiology Institute, Duke University, Durham, NC 27701, USA.
Ira TabasDepartment of Medicine, Columbia University, New York, NY 10032, USA; Department of Tumor Biology, Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA; Department of Pathology and Cell Biology, Columbia University, New York, NY 10032, USA; Department of Physiology, Columbia University, New York, NY 10032, USA. Electronic address: iat1@columbia.edu.
Columbia University · USMoffitt Cancer Center · USDuke University · USLouisiana State University Health Sciences Center Shreveport · US

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Parisa Tehranifar · 1985 to 2026
$115.3M
Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5M
Translational Biomarker Analytical Core (TBAC)P30DK063608 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DOMENICO ACCILI · 2003 to 2026
$36.7M
TTC39B in obesity and atherosclerosisP01HL087123 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, NAN · 2007 to 2022
$31.2M
Stress Exacerbates Myocardial Ischemic Injury by Blocking Estrogen's Antidoxidant Protection in the Female HeartP20GM121307 · NIGMS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI Vesna Tesic · 2018 to 2026
$23.6M
POSTDOCTORAL TRAINING IN ARTERIOSCLEROSIS RESEARCHT32HL007343 · NHLBI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI HENRY N GINSBERG, Muredach P Reilly · 1985 to 2026
$12.7M
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosisU01HL134760 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SNOECK, HANS-WILLEM E, VUNJAK-NOVAKOVIC, GORDANA · 2016 to 2022
$8.5M
Role of Carnitine Acetyltransferase in Mitochondrial and Metabolic FunctionR01DK089312 · NIDDK · DUKE UNIVERSITY · PI DEBORAH M MUOIO · 2010 to 2026
$7.8M
A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic PlaquesR35HL145228 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TABAS, IRA A · 2019 to 2025
$6.8M
Probing the Role of Mitochondrial Short-chain Carbon Homeostasis in the Hypertrophied and Failing HeartR01HL128349 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MUOIO, DEBORAH M · 2016 to 2024
$6.1M
The Unfolded Protein Response in Sterol CytoxicityR01HL075662 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TABAS, IRA A · 2004 to 2017
$5.6M
NCATS NIH HHS UL1 TR001873NCI NIH HHS P30 CA013696NCI NIH HHS P30 CA076292NCRR NIH HHS S10 RR025686NHLBI NIH HHS F32 HL137398NHLBI NIH HHS K99 HL145131NHLBI NIH HHS P01 HL087123NHLBI NIH HHS R01 HL075662NHLBI NIH HHS R01 HL127464NHLBI NIH HHS R01 HL128349NHLBI NIH HHS R01 HL132412NHLBI NIH HHS R01 HL149264NHLBI NIH HHS R35 HL145228NHLBI NIH HHS T32 HL007343NHLBI NIH HHS U01 HL134760NIDDK NIH HHS P30 DK063608NIDDK NIH HHS R01 DK089312NIGMS NIH HHS P20 GM121307NIH HHS S10 OD020056
6 · The paper itself

Abstract

Continual efferocytic clearance of apoptotic cells (ACs) by macrophages prevents necrosis and promotes injury resolution. How continual efferocytosis is promoted is not clear. Here, we show that the process is optimized by linking the metabolism of engulfed cargo from initial efferocytic events to subsequent rounds. We found that continual efferocytosis is enhanced by the metabolism of AC-derived arginine and ornithine to putrescine by macrophage arginase 1 (Arg1) and ornithine decarboxylase (ODC). Putrescine augments HuR-mediated stabilization of the mRNA encoding the GTP-exchange factor Dbl, which activates actin-regulating Rac1 to facilitate subsequent rounds of AC internalization. Inhibition of any step along this pathway after first-AC uptake suppresses second-AC internalization, whereas putrescine addition rescues this defect. Mice lacking myeloid Arg1 or ODC have defects in efferocytosis in vivo and in atherosclerosis regression, while treatment with putrescine promotes atherosclerosis resolution. Thus, macrophage metabolism of AC-derived metabolites allows for optimal continual efferocytosis and resolution of injury.

Indexed as

AnimalsApoptosisArginaseArginineELAV-Like Protein 1Gene DeletionGuanine Nucleotide Exchange FactorsHumansJurkat CellsMacrophagesMaleMice, Inbred C57BLMyeloid CellsOrnithine DecarboxylasePhagocytosisPutrescineArginaseArginineElavl1 protein, mouseELAV-Like Protein 1Guanine Nucleotide Exchange FactorsMcf2 protein, mouseOrnithine DecarboxylasePutrescinerac1 GTP-Binding ProteinRNA, Messengerarginasearginineatherosclerosisatherosclerosis regressionefferocytosisinflammation resolutionintracellular metabolismmacrophagepolyaminesputrescine

Identifiers

PMID32004476
PMCPMC7173557
OpenAlexW3004079464

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.